Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$1.24 - $2.33 $744 - $1,398
-600 Closed
0 $0
Q4 2021

Jan 27, 2022

BUY
$4.65 - $7.23 $465 - $723
100 Added 20.0%
600 $3,000
Q2 2021

Aug 03, 2021

BUY
$6.35 - $10.0 $1,905 - $3,000
300 Added 150.0%
500 $5,000
Q2 2020

Jul 30, 2020

BUY
$1.73 - $6.76 $346 - $1,352
200 New
200 $1,000
Q4 2018

Jan 30, 2019

SELL
$2.01 - $4.24 $15,476 - $32,648
-7,700 Closed
0 $0
Q1 2018

May 03, 2018

BUY
$4.5 - $9.95 $21,150 - $46,765
4,700 Added 156.67%
7,700 $40,000
Q4 2017

Feb 06, 2018

BUY
$1.75 - $3.8 $5,250 - $11,400
3,000
3,000 $11,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Community Bank, N.A. Portfolio

Follow Community Bank, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Community Bank, N.A. with notifications on news.